» Articles » PMID: 24348535

International Consensus Diagnostic Criteria for Autoimmune Pancreatitis and Its Japanese Amendment Have Improved Diagnostic Ability over Existing Criteria

Overview
Publisher Wiley
Specialty Gastroenterology
Date 2013 Dec 19
PMID 24348535
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives. The recent International Consensus Diagnostic Criteria (ICDC) for autoimmune pancreatitis (AIP) and its Japanese amendment developed by the Japanese Pancreas Society (JPS 2011) may have overcome the drawbacks of earlier criteria and achieved a higher diagnostic ability for AIP. The aim of the present study is to evaluate this possibility and identify the underlying causes of this change. Methods. We compared the diagnostic abilities of the ICDC and JPS 2011 with those of the Japanese diagnostic criteria 2006 (JPS 2006), Korean diagnostic criteria (Korean), Asian diagnostic criteria (Asian), and HISORt diagnostic criteria in 110 patients with AIP and 31 patients with malignant pancreatic cancer. Results. The ICDC achieved the highest diagnostic ability in terms of accuracy (95.0%), followed by JPS 2011 (92.9%), Korean (92.2%), HISORt (88.7%), Asian (87.2%), and JPS 2006 (85.1%). Nearly all criteria systems exhibited a high specificity of 100%, indicating that the enhanced diagnostic ability of the ICDC and JPS 2011 likely stemmed from increased sensitivity brought about by inclusion of diagnostic items requiring no endoscopic retrograde pancreatography. The diagnostic ability of JPS 2011 was nearly equivalent to that of the ICDC. Conclusions. The ICDC and JPS 2011 have improved diagnostic ability as compared with earlier criteria sets because of an increase in sensitivity.

Citing Articles

Chronic Pancreatitis: One Patient, Multiple Etiologies.

Vieira Afonso J, Santos M, Vieira J, Durao-Carvalho G, Rodrigues A Cureus. 2025; 17(1):e77947.

PMID: 39996177 PMC: 11848220. DOI: 10.7759/cureus.77947.


The Role of Endoscopic Ultrasound and Ancillary Techniques in the Diagnosis of Autoimmune Pancreatitis: A Comprehensive Review.

Metelli F, Manfredi G, Pagano N, Buscarini E, Crino S, Armellini E Diagnostics (Basel). 2024; 14(12).

PMID: 38928649 PMC: 11202526. DOI: 10.3390/diagnostics14121233.


Autoimmune Pancreatitis: From Pathogenesis to Treatment.

Nista E, De Lucia S, Manilla V, Schepis T, Pellegrino A, Ojetti V Int J Mol Sci. 2022; 23(20).

PMID: 36293522 PMC: 9604056. DOI: 10.3390/ijms232012667.


Affinity Purification Coupled to Stable Isotope Dilution LC-MS/MS Analysis to Discover IgG4 Glycosylation Profiles for Autoimmune Pancreatitis.

Chen M, Su H, Shiao C, Chang Y, Chang M, Kao C Int J Mol Sci. 2021; 22(21).

PMID: 34768956 PMC: 8584136. DOI: 10.3390/ijms222111527.


Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.

Jia H, Li J, Huang W, Lin G BMC Med Imaging. 2021; 21(1):149.

PMID: 34654379 PMC: 8518199. DOI: 10.1186/s12880-021-00679-0.


References
1.
Kamisawa T, Imai M, Yui Chen P, Tu Y, Egawa N, Tsuruta K . Strategy for differentiating autoimmune pancreatitis from pancreatic cancer. Pancreas. 2008; 37(3):e62-7. DOI: 10.1097/MPA.0b013e318175e3a0. View

2.
Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I . Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol. 2006; 41(7):626-31. PMC: 2780630. DOI: 10.1007/s00535-006-1868-0. View

3.
Kwon S, Kim M, Choi E . The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus. Pancreas. 2007; 34(3):279-86. DOI: 10.1097/MPA.0b013e31802eff5f. View

4.
Kim M, Kwon S . Diagnostic criteria for autoimmune chronic pancreatitis. J Gastroenterol. 2007; 42 Suppl 18:42-9. DOI: 10.1007/s00535-007-2050-z. View

5.
Kawa S, Okazaki K, Kamisawa T, Shimosegawa T, Tanaka M . Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol. 2010; 45(4):355-69. DOI: 10.1007/s00535-009-0197-5. View